EUVIMEDEUVIMED entdecken
Crossref

Utility of Optical Genome Mapping in Repeat Disorders

Mehmet Burak Mutlu iD, Taner Karakaya iD, Hamide Betül Gerik Çelebi iD, Fahrettin Duymuş iD, Serhat Seyhan iD, Sanem Yılmaz iD, Uluç Yiş iD, Tahir Atik iD, Mehmet Fatih Yetkin iD, Hakan Gümüş iD

Clinical Genetics · 2025

DOI: 10.1111/cge.14633 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genetics, 2025. Verfasst von Mehmet Burak Mutlu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Detagen Genetic Diseases Evaluation Center, Kayseri, Türkiye. Hauptthemen laut MEDLINE: Muscular Dystrophy, Facioscapulohumeral, Chromosome Mapping, Fragile X Syndrome, Friedreich Ataxia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genomic repeat sequences are patterns of nucleic acids that exist in multiple copies throughout the genome. More than 60 Mendelian disorders are caused by the expansion or contraction of these repeats. Various specific methods for determining tandem repeat variations have been developed. However, these methods are highly specific to the genomic region being studied and sometimes require specialized tools. In this study, we have investigated the use of Optical Genome Mapping (OGM) as a diagnostic tool for detecting repeat disorders. We evaluated 19 patients with a prediagnosis of repeat disorders and explained the molecular etiology of 9 of them with OGM (5 patients with Facioscapulohumeral Muscular Dystrophy (FSHD), 2 patients with Friedreich's Ataxia (FA), 1 patient with Fragile X Syndrome (FXS), and 1 patient with Progressive Myoclonic Epilepsy 1A (EPM1A)). We confirmed OGM results with more widely used fragment analysis techniques. This study highlights the utility of OGM as a diagnostic tool for repeat expansion and contraction diseases such as FA, FXS, EPM1A, and FSHD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, FacioscapulohumeralChromosome MappingFragile X SyndromeFriedreich AtaxiaHumansMaleFemaleGenome, HumanAdultChildDNA Repeat Expansion

Stichwörter der Autor:innen

BionanoFSHDFacioscapulohumeral Muscular DystrophyFragile X SyndromeFriedreich's AtaxiaOptical Genome MappingProgressive Myoclonic Epilepsy 1A

Autor:innen und Institutionen

  • Detagen Genetic Diseases Evaluation Center, Kayseri, Türkiye.
  • Department of Medical Genetics, Samsun Education and Research Hospital, Samsun, Türkiye.
  • Department of Medical Genetics, Balıkesir Ataturk City Hospital, Balıkesir, Türkiye.
  • Department of Medical Genetics, Konya City Hospital, Konya, Türkiye.
  • Laboratory of Genetics, Memorial Şişli Hospital, Istanbul, Türkiye.
  • Department of Pediatrics, Division of Pediatric Neurology, Ege University Faculty of Medicine, Izmir, Türkiye.

ORCID-Profile: Mehmet Burak Mutlu, Taner Karakaya, Hamide Betül Gerik Çelebi, Fahrettin Duymuş, Serhat Seyhan, Sanem Yılmaz, Uluç Yiş, Tahir Atik, Mehmet Fatih Yetkin, Hakan Gümüş

Zitieren

APA

Mutlu, M. B., Karakaya, T., Çelebi, H. B. G., Duymuş, F., Seyhan, S., Yılmaz, S., Yiş, U., Atik, T., Yetkin, M. F., & Gümüş, H. (2025). Utility of Optical Genome Mapping in Repeat Disorders. Clinical Genetics. https://doi.org/10.1111/cge.14633

Vancouver

Mutlu MB, Karakaya T, Çelebi HBG, Duymuş F, Seyhan S, Yılmaz S, et al. Utility of Optical Genome Mapping in Repeat Disorders. Clinical Genetics. 2025. doi:10.1111/cge.14633

BibTeX
@article{Mutlu2025,
  author = {Mutlu, Mehmet Burak and Karakaya, Taner and Çelebi, Hamide Betül Gerik and Duymuş, Fahrettin and Seyhan, Serhat and Yılmaz, Sanem and Yiş, Uluç and Atik, Tahir and Yetkin, Mehmet Fatih and Gümüş, Hakan},
  title = {Utility of Optical Genome Mapping in Repeat Disorders},
  journal = {Clinical Genetics},
  year = {2025},
  doi = {10.1111/cge.14633}
}
Kostenlos starten →